Dermatology Handbook
For UK audiences

The essential guide to product selection

DH
Fluorouracil 5% Cream
Actinic keratoses treatments Viatris

Fluorouracil 5% Cream

Topical cytostatic cream preparation with 5% fluorouracil that exerts a beneficial therapeutic effect on neoplastic and pre-neoplastic skin lesions without damaging normal skin. The pattern of response follows this sequence: erythema, vesiculation, erosion, ulceration, necrosis and epithelialisation. Formerly Efudix.

Indications

Topical treatment of superficial pre-malignant and malignant skin lesions.

Price

  • 40g, £32.90

Actinic keratoses treatments

All Actinic keratoses treatments
Actikerall 5mg/g + 100mg/g Cutaneous Solution
Almirall

Actikerall 5mg/g + 100mg/g Cutaneous Solution

A cutaneous solution containing 5 mg of fluorouracil and 100 mg of salicylic acid per 1g of solution.
Aldara
Viatris

Aldara

Cream containing 5% imiquimod, an immune response modifier that is effective against viral infections and acts as an anti-tumour agent, principally by induction of alpha interferon and other cytokines.
Klisyri 10mg/g Ointment
Almirall

Klisyri 10mg/g Ointment

An ointment for actinic keratosis containing 10mg/g tirbanibulin, applied daily over a 5-day course.
Metvix Cream
Galderma

Metvix Cream

After topical application of Metvix (methyl aminolevulinate), porphyrins accumulate intracellularly in the treated skin lesions. The intracellular porphyrins (including PplX) are photoactive, fluorescing compounds and, on light activation in the presence of oxygen, singlet oxygen is formed, which causes damage to cellular compartments, in particular the mitochondria. Light activation of accumulated porphyrins leads to a photochemical reaction and thereby phototoxicity to the light-exposed target cells
Solaraze 3% Gel
Almirall

Solaraze 3% Gel

An NSAID gel for actinic keratosis containing 3% diclofenac.
Zyclara
Viatris

Zyclara

Cream with 3.75% imiquimod, is an immune response modifier that is the lead compound of the imidazoline family.